Seriousness, preventability, and burden impact of reported adverse drug reactions in Lombardy emergency departments: a retrospective 2-year characterization

References

• MooreNBriffautCNobletCNormandCAThuillezCIndirect drug-related costsLancet199534589495885897776802
   PubMed Web of Science ®Google Scholar
• LazarouJPomeranzBHCoreyPNIncidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studiesJAMA199827915120012059555760
   PubMed Web of Science ®Google Scholar
• BeijerHJde BlaeyCJHospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studiesPharm World Sci2002242465412061133
   PubMed Web of Science ®Google Scholar
• PirmohamedMJamesSMeakinSAdverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patientsBMJ20043297456151915231615
   PubMed Web of Science ®Google Scholar
• PatelHBellDMolokhiaMTrends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998–2005BMC Clin Pharmacol20077917894876
   PubMedGoogle Scholar
• LeendertseAJVisserDEgbertsACvan den BemtPMThe relationship between study characteristics and the prevalence of medication-related hospitalizations: a literature review and novel analysisDrug Saf201033323324420158287
   PubMed Web of Science ®Google Scholar
• HohlCMNosykBKuramotoLOutcomes of emergency department patients presenting with adverse drug eventsAnn Emerg Med2011583270279. e27421354651
   PubMed Web of Science ®Google Scholar
• BudnitzDSLovegroveMCShehabNRichardsCLEmergency hospitalizations for adverse drug events in older AmericansN Engl J Med2011365212002201222111719
   PubMed Web of Science ®Google Scholar
• BatesDWSpellNCullenDJThe costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study GroupJAMA199727743073119002493
   PubMed Web of Science ®Google Scholar
• ZedPJAbu-LabanRBBalenRMIncidence, severity and preventability of medication-related visits to the emergency department: a prospective studyCMAJ2008178121563156918519904
   PubMed Web of Science ®Google Scholar
• HowardRLAveryAJHowardPDPartridgeMInvestigation into the reasons for preventable drug related admissions to a medical admissions unit: observational studyQual Saf Health Care200312428028512897361
   PubMedGoogle Scholar
• LagnaouiRMooreNFachJLongy-BoursierMBegaudBAdverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidabilityEur J Clin Pharmacol200056218118610877014
   PubMed Web of Science ®Google Scholar
• BudnitzDSPollockDAMendelsohnABWeidenbachKNMcDonaldAKAnnestJLEmergency department visits for outpatient adverse drug events: demonstration for a national surveillance systemAnn Emerg Med200545219720615671977
   PubMed Web of Science ®Google Scholar
• PatelKJKediaMSBajpaiDMehtaSSKshirsagarNAGogtayNJEvaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical emergency department of a tertiary referral centre: a prospective studyBMC Clin Pharmacol20077817662147
   PubMedGoogle Scholar
• AndreazzaRSSilveira De CastroMSippel KochePHeineckICauses of drug-related problems in the emergency room of a hospital in southern BrazilGac Sanit201125650150621835509
   PubMed Web of Science ®Google Scholar
• WasserfallenJLivioFBuclinTTilletLYersinBBiollazJRate, type, and cost of adverse drug reactions in emergency department admissionsEur J Intern Med200112544244711557331
   PubMedGoogle Scholar
• RashedANNeubertAAlhamdanHDrug-related problems found in children attending an emergency department in Saudi Arabia and in the United KingdomInt J Clin Pharm201335332733123549774
   PubMed Web of Science ®Google Scholar
• ZedPJHaughnCBlackKJMedication-related emergency department visits and hospital admissions in pediatric patients: a qualitative systematic reviewJ Pediatr2013163247748323465404
   PubMed Web of Science ®Google Scholar
• JouiniSDjebbiOSouissiSBouhajjaBIatrogenic adverse drug reaction in the emergency consultation of elderly people: epidemiological observational prospective studyLa Tunisie Medicale2013913200204 French23588635
   PubMedGoogle Scholar
• ChenYCFanJSChenMHRisk factors associated with adverse drug events among older adults in emergency departmentEur J Intern Med2014251495524200546
   PubMed Web of Science ®Google Scholar
• NickelCHRuedingerJMMessmerASDrug-related emergency department visits by elderly patients presenting with non-specific complaintsScand J Trauma Resusc Emerg Med2013211523497667
   PubMed Web of Science ®Google Scholar
• RendePPalettaLGallelliGRetrospective evaluation of adverse drug reactions induced by antihypertensive treatmentJ Pharmacol Pharmacother20134Suppl 1S47S5024347982
   PubMedGoogle Scholar
• SeeIShehabNKeglerSRLaskarSRBudnitzDSEmergency department visits and hospitalizations for digoxin toxicity: United States, 2005 to 2010Circ Heart Fail201471283424300242
   PubMed Web of Science ®Google Scholar
• JonesSCBudnitzDSSorbelloAMehtaHUS-based emergency department visits for fluoroquinolone-associated hypersensitivity reactionsPharmacoepidemiol Drug Saf201322101099110623963962
   PubMed Web of Science ®Google Scholar
• BanerjiARuddersSClarkSWeiWLongAACamargoCAJrRetrospective study of drug-induced anaphylaxis treated in the emergency department or hospital: patient characteristics, management, and 1-year follow-upJ Allergy Clin Immunol Pract201421465124565768
   PubMed Web of Science ®Google Scholar
• WuCBellCMWodchisWPIncidence and economic burden of adverse drug reactions among elderly patients in Ontario emergency departments: a retrospective studyDrug Saf201235976978122823502
   PubMed Web of Science ®Google Scholar
• HohlCMKuramotoLYuERogulaBStausbergJSobolevBEvaluating adverse drug event reporting in administrative data from emergency departments: a validation studyBMC Health Serv Res20131347324219303
   PubMed Web of Science ®Google Scholar
• RaschettiRMorguttiMMenniti-IppolitoFSuspected adverse drug events requiring emergency department visits or hospital admissionsEur J Clin Pharmacol1999541295996310192758
   PubMed Web of Science ®Google Scholar
• AhernFSahmLJLynchDMcCarthySDetermining the frequency and preventability of adverse drug reaction-related admissions to an Irish University Hospital: a cross-sectional studyEmerg Med J2014311242923389832
   PubMed Web of Science ®Google Scholar
• CalderLAForsterANelsonMAdverse events among patients registered in high-acuity areas of the emergency department: a prospective cohort studyCJEM201012542143020880432
   PubMedGoogle Scholar
• CapuanoAIrpinoAGalloMRegional surveillance of emergency-department visits for outpatient adverse drug eventsEur J Clin Pharmacol200965772172819294371
   PubMed Web of Science ®Google Scholar
• FriedmanSMProvanDMooreSHannemanKErrors, near misses and adverse events in the emergency department: what can patients tell us?CJEM200810542142718826729
   PubMedGoogle Scholar
• RouletLBallereauFHardouinJBAssessment of adverse drug event recognition by emergency physicians in a French teaching hospitalEmerg Med J2013301636722366041
   PubMed Web of Science ®Google Scholar
• TrifiroGCalogeroGIppolitoFMAdverse drug events in emergency department population: a prospective Italian studyPharmacoepidemiol Drug Saf200514533334015682429
   PubMed Web of Science ®Google Scholar
• CapuanoAMotolaGRussoFAdverse drug events in two emergency departments in Naples, Italy: an observational studyPharmacol Res200450663163615501703
   PubMed Web of Science ®Google Scholar
• The Uppsala Monitoring Centre, WHO Collaborating Centre for International Drug MonitoringGlossary of terms used in pharmacovigilance Available from: http://www.who-umc.org/graphics/25301.pdfAccessed February 16, 2014
   Google Scholar
• European Medicines AgencyDirective 2010/84/eu of the European Parliament and of the Council of 15 December 2010 amending, as regards pharmacovigilance, Directive 2001/83/EC on the Community code relating to medicinal products for human use Available from: http://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2010:348:0074:0099:EN:PDFAccessed October 19, 2014
   Google Scholar
• NaranjoCABustoUSellersEMA method for estimating the probability of adverse drug reactionsClin Pharmacol Ther19813022392457249508
   PubMed Web of Science ®Google Scholar
• SchumockGTThorntonJFocusing on the preventability of adverse drug reactionsHosp Pharm19922753810118597
   PubMedGoogle Scholar
• LauPMStewartKDooleyMJComment: hospital admissions resulting from preventable adverse drug reactionsAnn Pharmacother200337230330412549969
   PubMed Web of Science ®Google Scholar
• KongkaewCNoycePRAshcroftDMHospital admissions associated with adverse drug reactions: a systematic review of prospective observational studiesAnn Pharmacother20084271017102518594048
   PubMed Web of Science ®Google Scholar
• TafreshiMJMelbyMJKabackKRNordTCMedication-related visits to the emergency department: a prospective studyAnn Pharmacother199933121252125710630823
   PubMed Web of Science ®Google Scholar
• MalhotraSJainSPandhiPDrug-related visits to the medical emergency department: a prospective study from IndiaInt J Clin Pharmacol Ther2001391121811204932
   PubMed Web of Science ®Google Scholar
• DehoursEBounesVBagheriHValleBDucasseJLMontastrucJLAdverse drug reactions in an emergency medical dispatching centreEur J Clin Pharmacol201470788188724798891
   PubMed Web of Science ®Google Scholar
• WiffenPGillMEdwardsJMooreAAdverse drug reactions in hospital patients. A systematic review of the prospective and retrospective studiesBandolier Extra2002116
   Google Scholar
• Obreli-NetoPRNobiliAde Oliveira BaldoniAAdverse drug reactions caused by drug-drug interactions in elderly outpatients: a prospective cohort studyEur J Clin Pharmacol201268121667167622644345
   PubMed Web of Science ®Google Scholar
• NobiliALicataGSalernoFPolypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI studyEur J Clin Pharmacol201167550751921221958
   PubMed Web of Science ®Google Scholar
• KanjanaratPWintersteinAGJohnsTEHattonRCGonzalez-RothiRSegalRNature of preventable adverse drug events in hospitals: a literature reviewAm J Health Syst Pharm200360171750175914503111
   PubMed Web of Science ®Google Scholar
• HakkarainenKMGyllenstenHJonssonAKAndersson SundellKPetzoldMHaggSPrevalence, nature and potential preventability of adverse drug events – a population-based medical record study of 4970 adultsBr J Clin Pharmacol201478117018324372506
   PubMed Web of Science ®Google Scholar
• WintersteinAGSauerBCHeplerCDPooleCPreventable drug-related hospital admissionsAnn Pharmacother2002367–81238124812086559
   PubMed Web of Science ®Google Scholar
• ThomsenLAWintersteinAGSondergaardBHaugbolleLSMelanderASystematic review of the incidence and characteristics of preventable adverse drug events in ambulatory careAnn Pharmacother20074191411142617666582
   PubMed Web of Science ®Google Scholar
• HowardRLAveryAJSlavenburgSWhich drugs cause preventable admissions to hospital? A systematic reviewBr J Clin Pharmacol200763213614716803468
   PubMed Web of Science ®Google Scholar
• ShehabNPatelPRSrinivasanABudnitzDSEmergency department visits for antibiotic-associated adverse eventsClin Infect Dis200847673574318694344
   PubMed Web of Science ®Google Scholar
• LundkvistJJonssonBPharmacoeconomics of adverse drug reactionsFundam Clin Pharmacol200418327528015147278
   PubMed Web of Science ®Google Scholar
• GyllenstenHHakkarainenKMHaggSEconomic impact of adverse drug events – a retrospective population-based cohort study of 4970 adultsPLoS One201493e9206124637879
   PubMed Web of Science ®Google Scholar
• MooreNLecointreDNobletCMabilleMFrequency and cost of serious adverse drug reactions in a department of general medicineBr J Clin Pharmacol19984533013089517375
   PubMed Web of Science ®Google Scholar
• KalischLMCaugheyGERougheadREGilbertALThe prescribing cascadeAust Prescr201134162166
   Web of Science ®Google Scholar
• SenstBLAchusimLEGenestRPPractical approach to determining costs and frequency of adverse drug events in a health care networkAm J Health Syst Pharm200158121126113211449856
   PubMed Web of Science ®Google Scholar
• DetournayBFagnaniFPouyannePCost of hospitalizations for adverse drug effectsTherapie2000551137139 French10860015
   PubMed Web of Science ®Google Scholar
• Degli EspostiLSaragoniSBudaSSturaniADegli EspostiEGlycemic control and diabetes-related health care costs in type 2 diabetes; retrospective analysis based on clinical and administrative databasesClinicoecon Outcomes Res2013519320123696709
   PubMedGoogle Scholar
• RottenkolberDSchmiedlSRottenkolberMAdverse drug reactions in Germany: direct costs of internal medicine hospitalizationsPharmacoepidemiol Drug Saf201120662663421384463
   PubMed Web of Science ®Google Scholar
• GoettlerMSchneeweissSHasfordJAdverse drug reaction monitoring – cost and benefit considerations. Part II: cost and preventability of adverse drug reactions leading to hospital admissionPharmacoepidemiol Drug Saf19976Suppl 3S79S9015073758
   PubMed Web of Science ®Google Scholar
• GautierSBacheletHBordetRCaronJThe cost of adverse drug reactionsExpert Opin Pharmacother20034331932612614184
   PubMed Web of Science ®Google Scholar
• LeapeLLCullenDJClappMDPharmacist participation on physician rounds and adverse drug events in the intensive care unitJAMA1999282326727010422996
   PubMed Web of Science ®Google Scholar
• RouletLBallereauFHardouinJBChiffoleauAPotelGAsserayNAdverse drug event nonrecognition in emergency departments: an exploratory study on factors related to patients and drugsJ Emerg Med201446685786424565882
   PubMed Web of Science ®Google Scholar
• PiazzaGNguyenTNCiosDAnticoagulation-associated adverse drug eventsAm J Med2011124121136114222114827
   PubMed Web of Science ®Google Scholar